NCT05290688View on ClinicalTrials.gov

Cellular microRNA Signatures in Multiple Sclerosis

NAUnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

September 15, 2024

Study Completion Date

September 15, 2024

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

GENETIC

50 ml blodd sampling

50 ml blood sampling for genetic analysis (expression profiles of microRNAs)

Trial Locations (1)

75013

Hôpital La Pitié - Salpêtrière, Paris

Sponsors

Lead Sponsor

Institut Pasteur

All Listed Sponsors

collaborator

Höpital La Pitié-Salpêtrière

UNKNOWN

lead

Institut Pasteur

INDUSTRY

NCT05290688 - Cellular microRNA Signatures in Multiple Sclerosis | Biotech Hunter | Biotech Hunter